Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Russia Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20091
20102
20113
20143
20152
20162
20173
20181
20192
20202
20214
20221
20231
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated9
Active, not recruiting6
Recruiting5
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Petersburg State Pavlov Medical University8
Novartis Pharmaceuticals7
Federal Research Institute of Pediatric Hematology, Oncology and Immunology5
Janssen Research & Development, LLC3
Celgene2
AbbVie1
Celgene Corporation1
European Society for Blood and Marrow Transplantation1
Geron Corporation1
Ivan S Moiseev1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes35
Leukemia, Myeloid, Acute12
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Myeloproliferative Disorders7
Leukemia, Biphenotypic, Acute6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Graft vs Host Disease4
Lymphoma4
Anemia3
Leukemia, Myelomonocytic, Chronic3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.